Researchers at Cold Spring Harbor Laboratory developed BATCAVE, a comprehensive database of over 22,000 TCR-peptide interactions, and BATMAN, an AI-driven model that predicts T cell receptor peptide binding with improved accuracy. This technology addresses critical challenges in designing TCR therapies by mitigating off-target toxicity and improving predictions of immune interactions, supporting the development of safer and more effective personalized cancer and infectious disease immunotherapies.